首页> 美国卫生研究院文献>Cancer Biology Therapy >CLCA2 a target of the p53 family negatively regulates cancer cell migration and invasion
【2h】

CLCA2 a target of the p53 family negatively regulates cancer cell migration and invasion

机译:CLCA2是p53家族的靶标它负调控癌细胞的迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The tumor suppressor p53 transcriptionally regulates a number of genes that are involved in cell-cycle inhibition, apoptosis and the maintenance of genetic stability. Recent studies suggest that p53 also contributes to the regulation of cell migration and invasion. Here, we show that human chloride channel accessory-2 (CLCA2) is a target gene of the p53 family (p53, p73 and p63). CLCA2 is induced by DNA damage in a p53-dependent manner. The p53 family proteins activate the CLCA2 promoter by binding directly to the conserved consensus p53-binding site present in the CLCA2 promoter. In terms of function, ectopic expression of CLCA2 inhibited cancer cell migration. In contrast, silencing CLCA2 with siRNA stimulated cancer cell migration and invasion. We also found that inactivation of CLCA2 enhanced the expression of focal adhesion kinase (FAK), as well as its promoter activation. A small-molecule FAK inhibitor reduced the effect of CLCA2 siRNA on cell migration and invasion, suggesting that CLCA2 inhibits cancer cell migration and invasion through suppression of the FAK signaling pathway. Furthermore, there was an inverse correlation between CLCA2 and FAK expression in 251 human breast cancer tissues. These results strongly suggest that CLCA2 is involved in the p53 tumor suppressor network and has a significant effect on cell migration and invasion.
机译:肿瘤抑制因子p53转录调节许多与细胞周期抑制,凋亡和遗传稳定性维持有关的基因。最近的研究表明,p53也有助于调节细胞的迁移和侵袭。在这里,我们显示人类氯化物通道附件2(CLCA2)是p53家族(p53,p73和p63)的靶基因。 DNA损伤以p53依赖的方式诱导CLCA2。 p53家族蛋白通过直接结合存在于CLCA2启动子中的保守共有p53结合位点来激活CLCA2启动子。就功能而言,CLCA2的异位表达抑制了癌细胞的迁移。相反,用siRNA沉默CLCA2可刺激癌细胞迁移和侵袭。我们还发现灭活CLCA2增强了黏着斑激酶(FAK)的表达及其启动子的激活。一种小分子FAK抑制剂可降低CLCA2 siRNA对细胞迁移和侵袭的作用,这表明CLCA2通过抑制FAK信号通路来抑制癌细胞的迁移和侵袭。此外,在251个人乳腺癌组织中CLCA2和FAK表达之间存在负相关。这些结果强烈表明CLCA2参与了p53肿瘤抑制网络,并且对细胞迁移和侵袭具有重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号